Shelley Force Aldred
Gründer bei SwitchGear Genomics, Inc.
Profil
Shelley Force Aldred is the founder of SwitchGear Genomics, Inc. where she holds the title of President & Director since 2006.
She is also the founder of Rondo Therapeutics, Inc. where she holds the titles of Chief Executive & Financial Officer, Secretary since 2019.
Dr. Aldred is also the founder of Seismic Bio, Inc...
Dr. Aldred obtained a doctorate degree from Stanford University.
Aktive Positionen von Shelley Force Aldred
| Unternehmen | Position | Beginn |
|---|---|---|
SwitchGear Genomics, Inc.
 SwitchGear Genomics, Inc. BiotechnologyHealth Technology SwitchGear Genomics, Inc. provides products for studying regulatory elements in the human genome. It launches LightSwitch Synthetic Response Element which is used for understanding transcription factor activity in living cells. The firms endogenous human promoter vectors are used in primary screening assays to understand how drug candidates may affect biological pathways. The company was founded by Richard M. Myers, Nathan D. Trinklein and Shelley Force Aldred in 2006 and is headquartered in Menlo Park, CA. | Gründer | 01.01.2006 |
Seismic Bio, Inc.
 Seismic Bio, Inc. Pharmaceuticals: MajorHealth Technology Seismic Bio, Inc. is an American preclinical stage biopharmaceutical company that specializes in developing bispecific therapeutic antibodies to activate the immune system to fight cancer. The private company focuses on treating solid tumor types that do not respond to immune checkpoint inhibitors. Seismic Bio uses cutting-edge science at the intersection of genomics and immunology to create therapeutic bispecific antibodies that provide tuned and targeted stimulation to the immune system, ensuring broad therapeutic windows. The company was founded by Shelley Force Aldred, who has been the CEO since incorporation. | Vorstandsvorsitzender | - |
Rondo Therapeutics, Inc.
 Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | Vorstandsvorsitzender | 01.12.2019 |
Ausbildung von Shelley Force Aldred
| Stanford University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
SwitchGear Genomics, Inc.
SwitchGear Genomics, Inc. BiotechnologyHealth Technology SwitchGear Genomics, Inc. provides products for studying regulatory elements in the human genome. It launches LightSwitch Synthetic Response Element which is used for understanding transcription factor activity in living cells. The firms endogenous human promoter vectors are used in primary screening assays to understand how drug candidates may affect biological pathways. The company was founded by Richard M. Myers, Nathan D. Trinklein and Shelley Force Aldred in 2006 and is headquartered in Menlo Park, CA. | Health Technology |
Seismic Bio, Inc.
Seismic Bio, Inc. Pharmaceuticals: MajorHealth Technology Seismic Bio, Inc. is an American preclinical stage biopharmaceutical company that specializes in developing bispecific therapeutic antibodies to activate the immune system to fight cancer. The private company focuses on treating solid tumor types that do not respond to immune checkpoint inhibitors. Seismic Bio uses cutting-edge science at the intersection of genomics and immunology to create therapeutic bispecific antibodies that provide tuned and targeted stimulation to the immune system, ensuring broad therapeutic windows. The company was founded by Shelley Force Aldred, who has been the CEO since incorporation. | Health Technology |
Rondo Therapeutics, Inc.
Rondo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation. | Commercial Services |
